Rapid detection of rifampicin-resistant Mycobacterium tuberculosis by in-house, reverse line blot assay

Diagnostic Microbiology and Infectious Disease

Volumn 56, Issue 2, 2006, Pages 133-140

  Suresh, Naga ^a   Singh, Urvashi Balbir ^a   Arora, Jyoti ^a   Pande, Jitendra Nath ^b   Seth, Pradeep ^a   Samantaray, Jyotish Chandra ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b SITARAM BHARTIA INSTITUTE OF SCIENCE AND RESEARCH   (India)

Author keywords

Multidrug resistant; Reverse line blot assay; Rifampicin resistance; rpoB gene; Sequencing; Tuberculosis

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM MUTANT; CODON; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA SEQUENCE; GENOTYPE; MICROBIOLOGICAL EXAMINATION; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; REVERSE LINE BLOT ASSAY; SENSITIVITY AND SPECIFICITY; WILD TYPE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; HUMANS; IMMUNOBLOTTING; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SENSITIVITY AND SPECIFICITY;

EID: 33749236084     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.03.015     Document Type: Article

References (31)

1. Bartfai Z., Somoskovi A., Kodmon C., Szabo N., Puskas E., Kosztolanyi L., Farago E., Mester J., Parsons L.M., and Salfinger M. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J. Clin. Microbiol. 39 (2001) 3736-3739
2. Bobadilla-del-Valle M., Ponce-de-Leon A., Arenas-Huertero C., Vargas-Alarcon G., Kato-Maeda M., Small P.M., Couary P., Ruiz-Palacios G.M., and Sifuentes-Osornio J. rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism. Emerg. Infect. Dis. 7 (2001) 1010-1013
3. Caws M., and Drobniewski F.A. Molecular techniques in the diagnosis of Mycobacterium tuberculosis and the detection of drug resistance. Ann. N. Y. Acad. Sci. 953 (2001) 138-145
4. Cohn D.L., Bustreo F., and Raviglione M.C. Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUALTD global surveillance project. Clin. Infect. Dis. 24 Suppl. 1 (1997) S121-S130
5. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282 (1999) 677-686
6. Fan X.Y., Hu Z.Y., Xu F.H., Yan Z.Q., Guo S.Q., and Li Z.M. Rapid detection of rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates in Shanghai by using the amplification refractory mutation system. J. Clin. Microbiol. 41 (2003) 993-997
7. Farmer P., and Kim J.Y. Community based approaches to the control of multidrug resistant tuberculosis: Introducing "DOTS-plus". BMJ 317 (1998) 671-674
8. Felmlee T.A., Liu Q., Whelen A.C., Williams D., Sommer S.S., and Persing D.H. Genotypic detection of Mycobacterium tuberculosis rifampin resistance: Comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J. Clin. Microbiol. 33 (1995) 1617-1623
9. Garcia L., Alonso-Sanz M., Rebollo M.J., Tercero J.C., and Chaves F. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates in Spain and their rapid detection by PCR-enzyme-linked immunosorbent assay. J. Clin. Microbiol. 39 (2001) 1813-1818
10. Grange J.M. Drug-resistance and tuberculosis elimination. Bull. Int. Union Against Tuberc. Lung Dis. 65 (1990) 57
11. Heep M., Brandstatter B., Rieger U., Lehn N., Richter E., and Rusch-Gerdes S. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 39 (2001) 107-110
12. Heifets L.B., and Cangelosi G.A. Drug susceptibility testing of Mycobacterium tuberculosis: A neglected problem at the turn of the century. Int. J. Tuberc. Lung Dis. 3 (1999) 564-581
13. Iseman M.D. Treatment of multidrug-resistant tuberculosis. New Engl. J. Med. 329 (1993) 784-791
14. Jureen P., Werngren J., and Hoffner S.E. Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) 84 (2004) 311-316
15. Kamerbeek J., Schouls L., Kolk A., van Agterveld M., van Soolingen D., Kuijper S., Bunschoten A., Molhuizen H., Shaw R., Goyal M., and van Embden J. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35 (1997) 907-914
16. Kapur V., Li L.L., Iordanescu S., Hamrick M.R., Wanger A., Kreiswirth B.N., and Musser J.M. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32 (1994) 1095-1098
17. Kent P.T., and Kubica G.P. Public Health Mycobacteriology: A Guide for the Level III Laboratory (1985), Centers for Disease Control, Atlanta (GA)
18. Khatri G.R., and Friedan T.R. Controlling tuberculosis in India. New Engl. J. Med. 347 (2002) 1420-1425
19. Kwok S., and Higuchi R. Avoiding false positives with PCR. Nature 339 (1989) 237-238
20. Mani C., Selvakumar N., Narayanan S., and Narayanan P.R. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J. Clin. Microbiol. 39 (2001) 2987-2990
21. Morcillo N., Zumarraga M., Alito A., Dolmann A., Schouls L., Cataldi A., Kremer K., and van Soolingen D. A low cost, home-made, reverse-line blot hybridization assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 6 (2002) 59-65
22. Nash K.A., Gaytan A., and Inderlied C.B. Detection of rifampin resistance in Mycobacterium tuberculosis by means of a rapid, simple, and specific RNA/RNA mismatch. J. Infect. Dis. 176 (1997) 533-536
23. Siddiqi N., Shamim M., Hussain S., Choudhary R.K., Ahmed N., Prachee, et al. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob. Agents Chemother. 46 (2002) 443-450
24. Telenti I.A., Imboden P., Marchesi F., Lowrie D., Cole S., Colstonet M.J., et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341 (1993) 647-650
25. van den Brule A.J., Pol R., Fransen-Daalmeijer N., Schouls L.M., Meijer C.J., and Snijders P.J. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40 (2002) 779-787
26. van der Zanden A.G., Te Koppele-Vije E.M., Vijaya Bhanu N., Van Soolingen D., and Schouls L.M. Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis. J. Clin. Microbiol. 41 (2003) 1101-1108
27. Watterson S., Wilson S.M., Yates M.D., and Drobniewski F.A. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 36 (1998) 1969-1973
28. World Health Organisation. A Clinical Manual for South East Asia. Treatment of Tuberculosis-Guidelines for National Programme. WHO/TB/96.200 (1997), WHO, Geneva
29. World Health Organisation. Report on the TB Epidemic. WHO/TB/97.224 (1997), WHO, Geneva
30. Yue J., Shi W., Xie J., Li Y., Zeng E., and Wang H. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol. 41 (2003) 2209-2212
31. Zhang Y., Coyne M.Y., Will S.G., Levensen C.H., and Kawasaki E.S. Single-base mutational analysis of cancer and genetic diseases using membrane bound modified oligonucleotides. Nucleic. Acids Res. 19 (1991) 3929-3933